Yahoo
LSE - Delayed Quote GBp

Diaceutics PLC (DXRX.L)

202.50 -1.00 (-0.49%)
At close: 4:14:46 PM GMT
Chart Range Bar
Loading chart for DXRX.L
  • Previous Close 203.50
  • Open 205.00
  • Bid 200.00 x --
  • Ask 205.00 x --
  • Day's Range 200.00 - 205.00
  • 52 Week Range 125.00 - 210.00
  • Volume 188,627
  • Avg. Volume 215,434
  • Market Cap (intraday) 172.069M
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.00
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 213.00

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic event, enabling teams to act while treatment decisions are still pending; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers scientific and advisory services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

www.diaceutics.com

205

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

DXRX.L
59.38%
FTSE 100 (^FTSE)
8.44%

1-Year Return

DXRX.L
21.43%
FTSE 100 (^FTSE)
10.83%

3-Year Return

DXRX.L
140.00%
FTSE 100 (^FTSE)
44.63%

5-Year Return

DXRX.L
87.16%
FTSE 100 (^FTSE)
48.04%

Analyst Insights

View More

Analyst Price Targets

185.00 Low
213.00 Average
202.50 Current
235.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.66%

  • Return on Assets (ttm)

    -1.03%

  • Return on Equity (ttm)

    -0.71%

  • Revenue (ttm)

    41.33M

  • Net Income Avi to Common (ttm)

    -271k

  • Diluted EPS (ttm)

    -0.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.1M

  • Total Debt/Equity (mrq)

    5.40%

  • Levered Free Cash Flow (ttm)

    -449.62k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: